Stem cell-derived pancreatic islets are being studied as a rich transplantable source for insulin production, a therapeutic ...

Gene sequencing enabled researchers to identify the specific milk protein that triggered a patient’s eosinophilic esophagitis ...

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its ...

Detailed price information for Medicenna Therapeutics Corp (MDNA-T) from The Globe and Mail including charting and trades.

Immunocore Holdings' stock has dropped 60% as Kimmtrak faces market saturation, but its pipeline could offer potential. Find ...

Say goodbye to pesky scars. These best scar creams tackle everything from dark spots to atrophic scars, perfect for oily, dry ...

In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This ...

Medicenna’s long-acting IL-2 Superkine, MDNA11, is a next-generation IL-2 with superior affinity toward CD122 (IL-2 receptor beta) and no CD25 (IL-2 receptor alpha) binding, thereby preferentially ...

Modern medicine is experiencing a period of significant advancements and innovations, and at its core is radiopharmaceuticals ...

Bicara Therapeutics shows potential to reshape cancer care with ficerafusp alfa and robust funding post-IPO. Find out why ...

Editas Medicine, Inc.’s EDIT share price has dipped by 5.16%, which has investors questioning if this is right time to buy.

Some brands combine these with beetroot extract, another natural nitric oxide booster that doesn’t spike your heart rate ... Packed with key ingredients such as arginine alpha-ketoglutarate, ...